Psychiatry might need some psychedelic therapy
International Review of Psychiatry July 4, 2018 DOI: 10.1080/09540261.2018.1509544 (opens in new tab)
Study at a glance
AI-extracted from the abstract| Characteristics | Review Peer reviewed |
|---|---|
| Topics | Psychedelic-assisted therapy |
| Keywords | Psychotherapist Hallucinogen |
| Citations | 12 |
| Key findings | Psychedelic drugs have shown promise for managing psychiatric disorders, but controversies have limited their medical use. |
Abstract
In historical and modern-day studies, psychedelic drugs have shown promise in managing a variety of psychiatric disorders, but their medical use has often raised controversies. The controversies ha...
Comparable studies
Other narrative reviews on psychedelic-assisted therapy, most cited first.
Citations in the library
Cited by 10
- Classic psychedelics: An integrative review of epidemiology, therapeutics, mystical experience, and brain network function. Pharmacology & Therapeutics May 1, 2019
- Pivotal mental states Journal of Psychopharmacology April 1, 2021
- Integrating psychotherapy and psychopharmacology: psychedelic-assisted psychotherapy and other combined treatments Expert Review of Clinical Pharmacology June 1, 2020
- Moving beyond a figurative psychedelic literacy: Metaphors of psychiatric symptoms in ayahuasca narratives. Social Science & Medicine October 1, 2023
- Adverse events associated with classic psychedelics and MDMA: a real-world population-based study using the WHO pharmacovigilance database (VigiBase) Psychiatry Research December 29, 2025
and 5 more in the library
Cites 25
- Psilocybin produces substantial and sustained decreases in depression and anxiety in patients with life-threatening cancer: A randomized double-blind trial Journal of Psychopharmacology November 30, 2016
- Rapid and sustained symptom reduction following psilocybin treatment for anxiety and depression in patients with life-threatening cancer: a randomized controlled trial Journal of Psychopharmacology November 30, 2016
- Psilocybin with psychological support for treatment-resistant depression: an open-label feasibility study. The Lancet Psychiatry May 17, 2016
- Pilot Study of Psilocybin Treatment for Anxiety in Patients With Advanced-Stage Cancer Archives of General Psychiatry September 7, 2010
- Neural correlates of the psychedelic state as determined by fMRI studies with psilocybin Proceedings of the National Academy of Sciences January 23, 2012
and 20 more in the library